Figure 1.

Presence of GI symptoms in first group: prior to and after the PD diagnosis.

Note: First group consisted of 20 PD patients with GI-NMS that received Trimebutine 200 mg three times per day.

Abbreviations: GI, gastrointestinal; PD, Parkinson’s disease; NMS, nonmotor symptoms.